Strikingly, ablation of METTL3 in myeloid cells promoted tumor growth and metastasis, associated with decreased YTHDF1-mediated translation of SPRED2 and increased activation of NF-kB and STAT3 through the ERK pathway, leading to increased tumor growth and metastasis [220]. Here, METTL3 is linked to neoplasm.